Sepsis after major visceral surgery is associated with sustained and interferon-γ–resistant defects of monocyte cytokine production
Authors:
- Claus-Dieter HeideckeCHClaus-Dieter Heidecke
- Klaus EmmanuilidisKEKlaus Emmanuilidis
- Stefan MaierSMStefan Maier
- Holger BartelsHBHolger Bartels
- Jörg-Rüdiger SiewertJSJörg-Rüdiger Siewert
- Bernhard HolzmannBHBernhard Holzmann
Abstract
No abstract availableKeywords
This publication has 41 references indexed in Scilit:
- THE INTERLEUKIN-12/INTERLEUKIN-12-RECEPTOR SYSTEM: Role in Normal and Pathologic Immune ResponsesAnnual Review of Immunology, 1998
- Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shockThe Lancet, 1998
- Th1-Th2: Reliable paradigm or dangerous dogma?Immunology Today, 1997
- Interleukin (IL)-6 Directs the Differentiation of IL-4–producing CD4+ T CellsJournal of Experimental Medicine, 1997
- International sepsis trial (INTERSEPT)Critical Care Medicine, 1996
- IL-12: a key cytokine in immune regulationImmunology Today, 1996
- The Instructive Role of Innate Immunity in the Acquired Immune ResponseScience, 1996
- New therapeutic approaches in sepsis: A critical reviewIntensive Care Medicine, 1995
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.Journal of Experimental Medicine, 1993
- Definitions for Sepsis and Organ Failure and Guidelines for the Use of Innovative Therapies in SepsisChest, 1992